Back to top

Ono’s New GIST Study Puts Early???Stage Oncology Back in Focus for OPHLF Investors

ONO Pharmaceutical Co ($OPHLF) announced an update on their ongoing clinical study. Ono Pharmaceutical Co., Ltd. (OPHLF) is running a Phase 1 study...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ono Pharmaceutical Co. (OPHLF)